腹腔化疗在治疗和防止胃癌术后腹腔内复发转移上比传统静脉化疗具有优势。
Intraperitoneal chemotherapy has more supremacy than traditional vein chemotherapy in control and treatment of recrudescence and diversion at peritoneal for gastric cancer patient after operation.
目的探讨腹腔内化疗在中晚期胃肠癌治疗中的价值。
Objective To evaluate the value of intraperitoneal chemotherapy in moderate advanced gastrointestinal cancer.
目的探讨腹腔化疗在卵巢癌患者术后化疗中的价值。
Objective to study the value of intraperitoneal chemotherapy after operation on the patients with ovarian cancer.
目的探讨术中腹腔内温热灌注(IPHP)化疗在中晚期大肠癌中的临床价值。
Objective to determine the clinical value of intraperitoneal hyperthermic perfusion (IPHP) chemotherapy in preventing postoperative recurrence of advanced colorectal cancer.
结论：在中晚期消化道肿瘤，尤其伴有腹水病人治疗中，采用持续腹腔热灌注化疗可明显提高治疗效果。
Conclusions: CHPP on patients with late digestive tract cancer, especially those patients followed by ascites, can evidently enhance the effectiveness of the treatment.
结果表阿霉素在术后早期腹腔内化疗时腹腔液峰值浓度比外周静脉高228倍，且持续时间长；腹腔液总平均浓度比外周静脉高167倍。
Results: the peak and the mean levels of epirubicin in the peritoneal fluid were 228 and 167 times higher than the corresponding peripheral vein levels.
结论：CHIP腹腔ddp浓度高，血浆峰值较低，以及高温作用，有利于化疗药物在局部对肿瘤细胞发挥作用，减少肾毒性和全身副作用。
Conclusion: CHIP provides high concentration of DDP in the peritoneal cavity, inducing higher local tumoricidal effect, lower nephric and systemic toxicity.
结论：CHIP腹腔ddp浓度高，血浆峰值较低，以及高温作用，有利于化疗药物在局部对肿瘤细胞发挥作用，减少肾毒性和全身副作用。
Conclusion: CHIP provides high concentration of DDP in the peritoneal cavity, inducing higher local tumoricidal effect, lower nephric and systemic toxicity.
应用推荐